Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 26 September 2024

This extraordinary CHMP meeting is organised to discuss emerging data with the sickle cell disease medicine Oxbryta (voxelotor).

German is available via eTranslation, the European Commission's machine translation service.

Translate to German | Important information about machine translation

Date

, -

Ort

Online
European Medicines Agency, Amsterdam, the Netherlands

The Committee for Medicinal Products for Human Use (CHMP) is responsible for preparing the European Medicines Agency's opinions on all questions concerning human medicines.

Share this page